- Home
- ROIV vs FLS Comparison
ROIV vs FLS Comparison
Compare ROIV & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- FLS
- Stock Information
- Founded
- ROIV 2014
- FLS 1790
- Country
- ROIV United Kingdom
- FLS United States
- Employees
- ROIV N/A
- FLS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- FLS Fluid Controls
- Sector
- ROIV Health Care
- FLS Industrials
- Exchange
- ROIV Nasdaq
- FLS Nasdaq
- Market Cap
- ROIV 8.6B
- FLS 7.1B
- IPO Year
- ROIV N/A
- FLS N/A
- Fundamental
- Price
- ROIV $14.18
- FLS $56.26
- Analyst Decision
- ROIV Strong Buy
- FLS Strong Buy
- Analyst Count
- ROIV 4
- FLS 9
- Target Price
- ROIV $15.50
- FLS $66.89
- AVG Volume (30 Days)
- ROIV 6.8M
- FLS 1.6M
- Earning Date
- ROIV 11-11-2025
- FLS 10-27-2025
- Dividend Yield
- ROIV N/A
- FLS 1.50%
- EPS Growth
- ROIV N/A
- FLS 13.91
- EPS
- ROIV N/A
- FLS 2.21
- Revenue
- ROIV $23,233,000.00
- FLS $4,646,070,000.00
- Revenue This Year
- ROIV N/A
- FLS $6.59
- Revenue Next Year
- ROIV $281.14
- FLS $4.10
- P/E Ratio
- ROIV N/A
- FLS $25.28
- Revenue Growth
- ROIV N/A
- FLS 3.15
- 52 Week Low
- ROIV $8.73
- FLS $37.34
- 52 Week High
- ROIV $14.48
- FLS $65.08
- Technical
- Relative Strength Index (RSI)
- ROIV 75.19
- FLS 52.49
- Support Level
- ROIV $13.81
- FLS N/A
- Resistance Level
- ROIV $14.48
- FLS $57.57
- Average True Range (ATR)
- ROIV 0.43
- FLS 1.01
- MACD
- ROIV 0.17
- FLS -1.85
- Stochastic Oscillator
- ROIV 88.76
- FLS 97.72
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.